Results 101 to 110 of about 820 (178)

UP-NEXT (GOG-3049/ENGOT-Ov71-NSGO-CTU): A study of Upitifamab Rilsodotin (UpRi), a NaPi2b-directed antibody drug conjugate in platinum-sensitive recurrent ovarian cancer (1248) [PDF]

, 2023
Debra L. Richardson, Philipp Harter, David M. O’Malley, Antonio González-Martı́n, Thomas J. Herzog, Caroline Rogalski, Robert A. Burger, Mansoor Raza Mirza   +7 more
openalex   +1 more source

Supplementary Figures from The Dolaflexin-based Antibody–Drug Conjugate XMT-1536 Targets the Solid Tumor Lineage Antigen SLC34A2/NaPi2b

, 2023
Natalya D. Bodyak, Rebecca Mosher, Aleksandr V. Yurkovetskiy, Ying Mao, Charlie Bu, Patrick R. Conlon, Damon R. Demady, Michael J. DeVit, Dmitry R. Gumerov, Venu R. Gurijala, Winnie Lee, Dennis J. McGillicuddy, Peter U. Park, Laura L. Poling, Marina Protopova, LiuLiang Qin, Cheri A. Stevenson, Elena Ter‐Ovanesyan, Alex Uttard, Dongmei Xiao, Jian Xu, Ling Xu, Donald A. Bergstrom, Timothy B. Lowinger   +23 more
openalex   +1 more source

Dolaflexin Manuscript Figures 2-6 from The Dolaflexin-based Antibody–Drug Conjugate XMT-1536 Targets the Solid Tumor Lineage Antigen SLC34A2/NaPi2b

, 2023
Natalya D. Bodyak, Rebecca Mosher, Aleksandr V. Yurkovetskiy, Ying Mao, Charlie Bu, Patrick R. Conlon, Damon R. Demady, Michael J. DeVit, Dmitry R. Gumerov, Venu R. Gurijala, Winnie Lee, Dennis J. McGillicuddy, Peter U. Park, Laura L. Poling, Marina Protopova, LiuLiang Qin, Cheri A. Stevenson, Elena Ter‐Ovanesyan, Alex Uttard, Dongmei Xiao, Jian Xu, Ling Xu, Donald A. Bergstrom, Timothy B. Lowinger   +23 more
openalex   +2 more sources

Generation of a DUX4-TetOn naïve human embryonic stem cell line [PDF]

, 2023
Korhonen, Anni
core  

Value of Antibody Drug Conjugates for Gynecological Cancers: A Modern Appraisal Following Recent FDA Approvals. [PDF]

Int J Womens Health, 2023
McNamara B, Chang Y, Goreshnik A, Santin AD.   +3 more
europepmc   +1 more source

TUB-040, a Homogeneous and Hydrophilic NaPi2b-Targeting ADC with Stably Linked Exatecan, Exhibits Long-lasting Antitumor Activity and a Well-Tolerated Safety Profile. [PDF]

Mol Cancer Ther
Vogl AM, Schmitt S, Mai I, Machui P, Herterich S, Leonardi N, Cyprys P, Hauswald D, Ochtrop P, Kozlowska I, Kitowski A, Gerlach M, Waldmann F, Marcq O, Trail PA, Schumacher D, Fingerle-Rowson GR, Hock B, Kasper MA, Helma J.   +19 more
europepmc   +1 more source

Managing Phosphate Burden in Patients Receiving Dialysis: Beyond Phosphate Binders and Diet. [PDF]

Kidney360, 2023
Kalantar-Zadeh K, Forfang D, Bakris G, Martin KJ, Moe SM, Sprague SM.   +5 more
europepmc   +1 more source

Supplementary Figure 10 from TUB-040, a Homogeneous and Hydrophilic NaPi2b-Targeting ADC with Stably Linked Exatecan, Exhibits Long-lasting Antitumor Activity and a Well-Tolerated Safety Profile

Annette M. Vogl, Saskia Schmitt, Isabelle Mai, Paul Machui, Sarah Herterich, Natascia Leonardi, Philipp Cyprys, Danila Hauswald, Philipp Ochtrop, Izabela Kozlowska, Annabel Kitowski, Marcus Gerlach, Florian Waldmann, Olivier Marcq, Pamela A. Trail, Dominik Schumacher, Günter R. Fingerle-Rowson, Björn Hock, Marc‐André Kasper, Jonas Helma   +19 more
openalex   +1 more source

Recognition of mutant forms of the sodium-dependent phosphate transporter NaPi2b by monoclonal antibodies in ovarian cancer cells

, 2022
L.F. Bulatova, V. Skripova, Arina V. Korotaeva, Mikhail Bogdanov, Ramziya Kiyamova   +4 more
openalex   +1 more source

SLC34A2 inhibits tumorigenesis and progression via upregulating LRRK2/TTF-1/SELENBP1 axis in lung adenocarcinoma. [PDF]

Cancer Gene Ther
Zhu Y, An N, Zhang Q, Liu Y, Gu P, Zhao J, Pan W, Pu Q, Wen Z.   +8 more
europepmc   +1 more source